🚨💥😉Out today Journal of Clinical Oncology Phenomenal effort led by amazing team Talal El Zarif, MD Amin Nassar, MD Elio Adib Guru P. Sonpavde, MD with collaboration across 🌎 adding to an understudied question of #HIV and #Immunotherapy. Thank you Journal of Clinical Oncology Jonathan Friedberg for publishing this work!

Excited to see the important results of BV-AVD in HIV+ Hodgkin lymphoma in print! 2-yr PFS 87% and OS 92% plus increases CD4/CD8 counts. Great work by Paul Rubinstein and AMC Operations sciencedirect.com/science/articl…

Out today in collaboration with ASCO, Dr. Reizine & I discuss why exercise is important for patients with prostate cancer, common challenges & types of exercises that may be helpful! 🏃‍♂️🚴🏽 🧘‍♂️ 🏋🏽‍♀️ #prostatecancer #guonc cancer.net/blog/2023-08/w…

It is the only way

the best plate ever, though this hiv lymphoma doc is biased

How I Treat Post-Transplant Lymphoproliferative Disorder ashpublications.org/blood/article-… Jennifer Amengual Herbert Irving Comprehensive Cancer Center NewYork-Presbyterian

I'm excited to share that our new paper is published. Many thanks to our wonderful team that made this possible. We are also grateful to the clinical trial participants for their contributions. #kshv #hhv8 #RNAseq #herpes #virus #OpenAccess doi.org/10.1186/s12967…

Art of Oncology Special Edition ... honoring the personal stories that have touched our ❤️ and made us cry. I still go back to many of these and read them. We should take pauses in our busy lives and reflect on how humbling it is to treat cancer ascopubs.org/jco/art-of-onc…

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study - Rajdev - Cancer - Wiley Online Library acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

New! Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Jason Luke, MD, FACP, FASCO AMC Operations

Rutherford et al - BV-AVD v N-AVD in older Hodgkin - SWOG 1836 study, 60y+, n=103 (approx 50 each arm) - med age 66, more high risk in N-AVD - Less tox with N-AVD: GI, PN, sepsis - 1y PFS 64v93% - 1y OS 83v95% (not stat signif) - NRM 4v14% A game changer. #ASH23 #lymsm

N-AVD vs BV-AVD in older patients with #Hodgkin #lymphoma. No words needed. To me, the new SoC #lymsm #ASH23

A prospective approach linking individual level pt reported SDOH data to early adverse AML outcomes. Proud of Eshana Shah for an excellent oral abstract and the dedicated efforts of leukemia teams, trainees and patients University of Illinois Cancer Center and Lurie Cancer Center

#ASH23 Thank you to my amazing mentors Matthew Cortese, MD, MPH Francisco Hernandez Paul Rubinstein and colleagues for visiting my poster and show support! Roswell Park Hematology/Oncology Fellowship #lymsm

CONGRESS | #ASH23 | Franck Morschhauser, University of Lille, presents a post-hoc analysis of the POLARIX study on the prevalence & clinical outcomes of molecularly defined subtypes of DLBCL. N=594, high-risk DHL/THL patients with DZsigPos DLBCL may benefit from Pola-R-CHP vs

Some of our 3rd year fellows Dr. Maahs & Dr. Avila presenting their research ASH #ASH23 🩸 University of Illinois Cancer Center

Congrats to our all ⭐️ graduating fellows!! Dr. Kevin Prescott Dr. Ana Maria Avila Dr. Lucas Maahs We are so excited for what the future holds for you all! University of Illinois Cancer Center

Poster presentation at @asco #GU25 by our fellow Dr. Michael Weinfeld looking at low-dose abiraterone adherence/cost vs standard dose abiraterone 💊

Breaking news from #CROI2025: Two probable HIV cures, the Chicago and Oslo Patients, were announced. If confirmed, the total number of known cures will rise to 10. Read article: amfar.org/news/researche…

At #CROI2025, our physician researcher Paul Rubinstein of University of Illinois Chicago UI Health presented findings from Chicago Patient (8th person living w/ HIV in remission off #ART after CCR5d32/d32 allogeneic stem cell transplant). NIAID News,#NIAIDVRC,National Cancer Institute & Cook County Health collab vital.